Translating Cell-Based Regenerative Medicines from Research to Successful Products: Challenges and Solutions

What matters most in commercial success: first-in-class or best-in-class?

(2013) Ulrik Schulze et al.   NATURE REVIEWS DRUG DISCOVERY

Commercialization of Regenerative Products: The Academic/Industry Partnership

(2013) Yves Bayon et al.   TISSUE ENGINEERING PART B-REVIEWS

Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial

(2012) Robert S Kirsner et al.   LANCET

The Regulatory Imperative: International Perspective

(2012) Tim Bertram et al.   TISSUE ENGINEERING PART B-REVIEWS

PRICING OF MEDICAL DEVICES UNDER COVERAGE UNCERTAINTY-A MODELLING APPROACH

(2011) Alan J. Girling et al.   HEALTH ECONOMICS

Early-Stage Valuation of Medical Devices: The Role of Developmental Uncertainty

(2010) Alan Girling et al.   VALUE IN HEALTH

A review of tissue-engineered skin bioconstructs available for skin reconstruction

(2009) R. V. Shevchenko et al.   Journal of the Royal Society Interface

Considerations for Tissue-Engineered and Regenerative Medicine Product Development Prior to Clinical Trials in the United States

(2009) Mark H. Lee et al.   TISSUE ENGINEERING PART B-REVIEWS